Study sheds light on global laboratory-acquired infections and pathogen escapes

Study analyzes global incidents of laboratory-acquired infections and accidental pathogen escapes from 2000 to 2021, highlighting the need for improved biosafety protocols and reporting systems.

APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a voluntary public purchase offer – Biotech Investments

EQS-News: APONTIS PHARMA AG / Key word(s): Tender Offer APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a voluntary

October 17, 2024

Vaxcyte aims to raise $1B after sharing pneumococcal vaccine data; More layoffs at Genentech

Plus, news about Anthos, Ascendis, Royalty Pharma, Semnur, Sonoma, Atara, Feldan, Indivior, Aelis Farma and Acepodia: Vaxcyte launches $1B offering: The Sign up to read

September 5, 2024

mRNA licensing agreements surge 800% amid GSK lawsuits – Pharmaceutical Technology

COVID-19 mRNA vaccines have sparked interest in the potential of mRNA technology, but they have also put producers at the centre of licensing lawsuits. Credit:

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.